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Abstract
Background: We previously demonstrated the small heat shock protein, HSPB1, to prevent tachycardia remodeling in in
vitro and in vivo models for Atrial Fibrillation (AF). To gain insight into its mechanism of action, we examined the protective
effect of all 10 members of the HSPB family on tachycardia remodeling. Furthermore, modulating effects of HSPB on RhoA
GTPase activity and F-actin stress fiber formation were examined, as this pathway was found of prime importance in
tachycardia remodeling events and the initiation of AF.
Methods and Results: Tachypacing (4 Hz) of HL-1 atrial myocytes significantly and progressively reduced the amplitude of
Ca
2+ transients (CaT). In addition to HSPB1, also overexpression of HSPB6, HSPB7 and HSPB8 protected against tachypacing-
induced CaT reduction. The protective effect was independent of HSPB1. Moreover, tachypacing induced RhoA GTPase
activity and caused F-actin stress fiber formation. The ROCK inhibitor Y27632 significantly prevented tachypacing-induced F-
actin formation and CaT reductions, showing that RhoA activation is required for remodeling. Although all protective HSPB
members prevented the formation of F-actin stress fibers, their mode of action differs. Whilst HSPB1, HSPB6 and HSPB7
acted via direct prevention of F-actin formation, HSPB8-protection was mediated via inhibition of RhoA GTPase activity.
Conclusion: Overexpression of HSPB1, as well as HSPB6, HSPB7 and HSPB8 independently protect against tachycardia
remodeling by attenuation of the RhoA GTPase pathway at different levels. The cardioprotective role for multiple HSPB
members indicate a possible therapeutic benefit of compounds able to boost the expression of single or multiple members
of the HSPB family.
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Introduction
Atrial Fibrillation (AF) is the most common sustained and
progressive clinical tachycardia in the population and it signifi-
cantly contributes to cardiovascular morbidity and mortality [1].
AF is characterized by specific changes in electrical, structural and
conctractile function of the atrial myocytes, commonly denoted as
‘remodeling’. Tachycardia remodeling underlies contractile dys-
function and the progressive and intractable nature of AF.
Therefore, remodeling is believed to have important therapeutic
implications, and there is great interest in developing anti-
remodeling therapies directed at the targets underlying remodeling
[1].
We recently identified one specific member of the heat shock
protein (HSP) family, HSPB1, to protect against AF-induced
remodeling [2;3]. HSPs are molecular chaperones and prevent the
accumulation of the misfolded or unfolded proteins in the cells [4].
HSPB1 is one member of the small heat shock protein (sHSP or
HSPB in mammals) family, which comprises a total of at least ten
members [5;6]. A characteristic of most HSPBs is their ability to
interact with components of the actin cytoskeleton, and this
binding protects against cytoskeletal injury during stress, resulting
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collectively share important features, including (1) a conserved a-
crystallin domain, (2) ability to form large oligomers in vitro and (3)
increased expression upon exposure to various stresses including
heat stress [8]. Nevertheless, the precise mode of action of HSPB1
to protect from tachycardia remodeling remains elusive and it is
unknown whether this is shared between other members of the
HSPB family. Therefore, we examined if, in addition to HSPB1,
also other HSPB members protect against atrial tachycardia
remodeling. Hereto, we utilized tachypaced HL-1 myocytes, an in
vitro atrial cell line model for tachycardia remodeling [3;9]. In
addition to HSPB1, we identified HSPB6, HSPB7 and HSPB8 to
protect against tachypacing-induced calcium transient reduction.
Because of the known protective actions of HSPBs on actin
cytoskeleton, we next examined their effect on tachypacing-
induced RhoA GTPase pathway, including RhoA GTPase activity
and related F-actin stress fiber formation. Although all protective
HSPB members reduced the formation of F-actin stress fibers,
their mode of action differs. HSPB1, HSPB6 and HSPB7 were
found to directly prevent F-actin stress fiber formation, whereas
HSPB8-protection was mediated via inhibition of upstream RhoA
GTPase activity.
Materials and Methods
2.1. HL-1 atrial myocyte culture, transfections and
constructs
HL-1 atrial myocytes, derived from adult mouse atria, were
obtained from Dr. William Claycomb as described before [3]. The
myocytes were maintained in Complete Claycomb Medium (JRH,
UK) supplemented with 100 mM norepinephrine (Sigma, The
Netherlands), 0.3 mM L-ascorbic acid (Sigma), 4 mM L-gluta-
mine (Gibco, The Netherlands) and 10% FBS (Life Technologies,
Gaithersburg, MD). They were cultured on coverslips coated with
12.5 mg/ml fibronectin (Sigma) and 0.02% gelatin (Sigma), in a
5% CO2 atmosphere at 37uC.
To study the influence of HSPBs on Ca
2+ transient changes,
HL-1 myocytes were transiently (co-)transfected, by the use of
Lipofectamin (Life Technologies, The Netherlands), with the
plasmid CD8 cDNA encoding CD8 antigen and/or pCDNA5/
FRT/TO-HSPBX (X indicating 1-10) encoding human HSPB
members. Positive myocytes were selected by anti-CD8 Dyna-
beads (Dynal). To check overexpression of HSPBX proteins in
HL-1 myocytes, myocytes were transiently transfected with the
fusion proteins V5-HSPBX. For all other experiments HSPBX
wildtype constructs were used.
2.2. Tachypacing of HL-1 myocytes
HL-1 myocytes were subjected to tachypacing as described
before [2;3;9]. In short, the spontaneous rate of HL-1 myocytes is
,1 Hz. HL-1 myocytes were subjected to normal electrical field
stimulation (1 Hz) for at least 30 min before tachypacing via the
C-Pace100
TM-Culture Pacer (IonOptix Corporation, The Nether-
lands). Tachypacing was performed at 4 Hz with 20-ms pulses for
8 hours to induce CaT reduction and 1 Hz pacing was used as a
control.
2.3. Protein-extraction and Western blot analysis
Western-blot analysis was performed as described previously
[2;3]. Equal amount of protein in SDS-PAGE sample buffer was
sonicated before separation on 10% PAA-SDS gels. After transfer
to nitrocellulose membranes (Stratagene, The Netherlands),
membranes were incubated with primary antibodies against
HSPB1 (SPA801, StressGen USA), V5 tag (Invitrogen, The
Netherlands) or GAPDH (Affinity Reagents, The Netherlands).
Horseradish peroxidase-conjugated anti-mouse or anti-rabbit
(Santa-Cruz Biotechnology, The Netherlands) was used as
secondary antibody. Signals were detected by the ECL-detection
method (Amersham, The Netherlands) and quantified by
densitometry.
2.4. Live imaging and measurement of CaT
To measure CaT, 2 mM of the Ca
2+-sensitive Fluo-4-AM dye
(Invitrogen, The Netherlands) was loaded into HL-1 myocytes by
45 min incubation, followed by 3 times washing with DMEM
solution. Ca
2+ loaded myocytes were excited by 488 nm and light
emitted at 500–550 nm and visually recorded with a 40x-
objective, using a Solamere-Nipkow-Confocal-Live-Cell-Imaging
system (based on a Leica DM IRE2 Inverted microscope). The live
recording of CaT in HL-1 myocytes was performed at 1 Hz of
stimulation in a temperature (37uC) controlled system. By use of
the software ImageJ (National Institutes of Health, USA), the
absolute value of fluorescent signals in live myocytes were recorded
and analyzed. To compare the fluorescent signals between
experiments, the following calibration was utilized: Fcal=F/F0,
in which (F) is fluorescent dye at any given time and (F0) is
fluorescent signal at rest [10]. Mean values from each experimen-
tal condition were based on 7 consecutive CaT in at least 50
myocytes.
2.5. Immunofluorescent staining and confocal analysis
Twenty-four hours after transient transfection of HSPB1,
HSPB5, HSPB6, HSPB7 and HSPB8, HL-1 myocytes were
subjected to (tachy)pacing. Afterwards, the myocytes were fixed
with 3.7% formaldehyde for 15 minutes, washed three times with
Phosphate-Buffered Saline (PBS), permeabilized with 0.2%
Triton-X100 and blocked with 0.1 glycine (10 minutes at room
temperature) and 5% BSA (30 minutes at room temperature).
Antibodies against HSPB6, HSPB7 and HSPB8 (all Abcam, The
Netherlands), and HSPB1 and HSPB5 (StressGen, USA) were
used as primary antibody. Fluorescein labeled isothiocyanate
(FITC) anti-mouse or anti-rabbit (Jackson ImmunoResearch, The
Netherlands) were used as secondary antibodies. To visualize F-
actin, rhodamine phalloidin (Invitrogen, The Netherlands) was
diluted with PBS at 1:40, followed by incubation for 20 minutes at
room temperature and washed three times with PBS. Images of
FITC and rhodamine fluorescence were obtained using the Leica
confocal laser scanning microscope (Leica SP2 AOBS) with 63X/
1.4 oil lens. The captured images were processed using Leica
Confocal Software and Adobe Photoshop. For determination of
the amount of F-actin stress fibers, the intensity of fluorescence was
analyzed by ImageJ in 5 independently taken fields. HL-1
myocytes were treated 4 hours prior and during (tachy)pacing
with the ROCK inhibitor Y27632 (10 mM, Sigma, The Nether-
lands) to prevent F-actin stress fiber formation. For determination
of the amount of colocalization of HSPB with stress fibers,
ImagePro software was used. The amount of colocalization was
determined as the ratio of total red signal (F-actin) divided by
yellow signal (colocalization HSPB with F-actin). Between 400 and
500 myocytes were quantified per condition.
2.6. Short interfering RNA of HSPB1 in combination with
over-expression of HSPB6, HSPB7 or HSPB8
Downregulation of endogenous HSPB1 was performed as
described previously [3]. HL-1 myocytes were transiently
transfected with HSPB1 siRNA or mock constructs for 5 days.
Furthermore, 24 hours before tachypacing, cells were co-trans-
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(tachy)pacing, CaT were measured and analyzed.
2.7. RhoA GTPase activity measurement with G-LISA
For the quantitative analysis of active RhoA GTP levels, G-
LISA RhoA Activation Assay (Cytoskeleton, USA) was performed
according to the manufacturer protocol. Briefly, 48 hours after the
transfection of HL-1 myocytes, myocytes were subjected to
(tachy)pacing for 6 hours or directly lysed in lysis buffer and cells
were harvested. After measurement of the protein concentration
with the use of Precision Red (supplied), equal amounts of lysates
were incubated in RhoA GTP affinity plates. The amount of
bound RhoA GTP was detected by using primary anti-RhoA
antibody (1:250, supplied) and secondary HRP-labeled antibody
(1:62.5, supplied). Colorimetric detection at 490 nm was per-
formed immediately (BioRad, The Netherlands).
2.8. Actin (de-)polymerization-assay
To determine the direct effect of HSPBs on actin polymeriza-
tion and depolymerization an actin polymerization biochem kit
(Cytoskeleton, USA) was used. Twenty-four hours after transient
transfection of HL-1 myocytes with HSPB1, HSPB5, HSPB6,
HSPB7 or HSPB8, myocytes were lysed in a mild lysis buffer
according to the manufacturer protocol. As a control, recombinant
human HSPB1 (Stressgen, USA) was dissolved in lysis buffer.
Base-line fluorescence of pyrene conjugated actin was measured
(Ex. 350 nm; Em. 405 nm) for three minutes, after which cell
lysates and recombinant HSPB1 were added to measure effect on
(de-)polymerization. Fluorescence was assayed every 60 s for
twenty minutes. Maximum actin polymerization was determined
by adding polymerization buffer.
2.9. Statistical analysis
Results are expressed as mean 6 SEM. All CaT measurements
were performed in at least triple series. Mean values from each
experimental condition were based on 7 consecutive CaT in at
least 50 myocytes. ANOVA was used for multiple-group
comparisons. All p-values were two-sided. P,0.05 was considered
statistically significant. SPSS version 16.0 was used for statistical
evaluation.
Results
3.1. Effect of overexpression of the ten different HSPB
members on tachypacing-induced remodeling in HL-1
myocytes
In humans, the HSPB family comprises a group of 10 members
with monomeric molecular weight varying between 16 to 28 kDa
[5;6;8]. Induction of HSPB1 has been shown previously to protect
against atrial tachypacing-induced remodeling, including CaT
reduction [3]. To study the effect of individual HSPB members,
HL-1 myocytes were transfected with V5 tagged constructs for
each member. All members were successfully overexpressed, albeit
HSPB8 and HSPB9 at a lower level (Figure 1A). As a control
group, HL-1 myocytes were transfected with an empty vector.
None of the overexpressed HSPB members changed CaT in
control myocytes paced at 1 Hz (data not shown). As observed
before [3], tachypacing at 4 Hz of HL-1 myocytes resulted in a
significant and progressive reduction in CaT (Figure S1), which
was attenuated by HSPB1 (Figure 1B,C Movie S1, Movie S2,
Movie S3). In addition, overexpression of HSPB6, HSPB7 and
HSPB8 also protected against tachypacing-induced CaT depres-
sion, whereas the other members were ineffective (Figure 1B,C
and Movie S1, Movie S2, Movie S3, Movie S4, Movie S5, Movie
S6, Movie S7, Movie S8, Movie S9, Movie S10, Movie S11,
Movie S12). These results indicate that in addition to HSPB1 also
HSPB6, HSPB7 and HSPB8 protect against tachypacing-induced
CaT reduction.
3.2. HSPB6, HSPB7 and HSPB8 protection against
tachypacing-induced CaT reduction is independent of
endogenous HSPB1 expression
HSPB members are known for their ability to form hetero-
oligomeric complexes [11;12] and given the fact that HSPB1 is
constitutively expressed in HL-1 myocytes, the possibility existed
that the protective effect of HSPB6, HSPB7 or HSPB8 on
tachypacing-induced CaT reduction was related to (indirect)
effects via (oligomerization with) HSPB1. Also, ectopic HSPB
expression may induce a stress response in cells leading to the up-
regulation of endogenous HSPB1. To exclude these possibilities, it
was first determined whether overexpression of HSPB6, HSPB7 or
HSPB8 increased expression of endogenous HSPB1 levels. As
shown in Figure 2, endogenous HSPB1 levels were similar after
normal pacing (1 Hz) and tachypacing (4 Hz), irrespective of
HSPB6, HSPB7 or HSPB8 overexpression. Secondly, the
endogenous HSPB1 level was suppressed by short hairpin RNAs
Figure 1. HSPB1, HSPB6, HSPB7 and HSPB8 overexpression
prevents against tachypacing-induced CaT reductions in HL-1
myocytes. (A) Representative Western blot showing overexpression of
HSPB1-10 in transiently transfected HL-1 myocytes. (B) Original
recordings of CaT in 1 myocyte each from groups indicated. (C) Mean
CaT data of HSPB1-10 overexpressing myocytes tachypaced (4 Hz) or
normal paced cells (1 Hz). **P,0.01, ***P,0.001 vs control tachypaced
(4 Hz). # P,0.001 vs control normal paced (1 Hz).
doi:10.1371/journal.pone.0020395.g001
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HSPB8 overexpression could still protect against tachypacing-
induced CaT reduction (Figure 3B,C, Movie S13, Movie S14,
Movie S15, Movie S16, Movie S17, Movie S18). In summary,
these results suggest that the protective effects of HSPB6, HSPB7
and HSPB8 against tachypacing-induced CaT reduction are
independent of HSPB1.
3.3. HSPB6, HSPB7 and HSPB8 reduce the amount of
F-actin stress fibers after tachypacing in HL-1 myocytes
Calcium signaling is known to be markedly influenced by the
stabilization of the cytoskeleton [13–15]. F-actin is one of the
major components of the cytoskeleton and located under the
plasma membrane to maintain cell shape, rigidity and integrity
[16;17]. Several HSPB members, including HSPB1, HSPB5,
HSPB6, HSPB7 and HSPB8, have been reported to be involved in
cytoskeletal stability [18–21]. To study if the underlying
mechanism for HSPB protection is related to effects on actin,
immunofluorescent staining was performed. We observed a 1.7
fold induction in the amount of F-actin stress fibers in tachypaced
HL-1 myocytes compared to normal paced control myocytes
(Figure 4, 5B), an effect that was significantly reduced by
overexpression of HSPB1, HSPB6, HSPB7 or HSPB8
(Figure 5A,B). Overexpression of HSPB5, which did not show
protection against tachypacing-induced CaT reductions (Figure 1),
also did not lead to a reduction in the amount of tachypacing-
induced F-actin stress fibers (Figure 4, 5B). Although in
tachypaced HSPB1, HSPB6, HSPB7 or HSPB8 overexpressing
myocytes a reduction in the amount of F-actin stress fibers was
found, HSPB1, HSPB6, HSPB7 and to a lesser extent HSPB8
colocalized with the F-actin residues after tachypacing and this was
not the case for HSPB5 (Figure 4, 5A,C). Taken together, these
results suggest that HSPB1, HSPB6, HSPB7 and HSPB8 prevent
the formation of F-actin stress fibers in tachypaced HL-1
myocytes, and thereby stabilize the cytoskeleton and myocyte
function.
3.4. Tachypacing induces RhoA GTPase and ROCK
activation, resulting in F-actin formation and reduction in
calcium transients
To confirm the role of RhoA GTPase pathway in
tachypacing-induced F-actin stress fiber formation and reduc-
tions in CaT, HL-1 myocytes were tachypaced for 0-8 hours
and RhoA GTPase activity was measured in cell lysates
(Figure 6A). A significant induction of the RhoA GTPase
activity was observed at 6 hours of tachypacing. In parallel, the
amount of F-actin was quantified. A gradual increase in the
amount of F-actin was observed during tachypacing, which was
prevented by the ROCK inhibitor Y27632 (10 mM) (Figure 6B).
In addition, also tachypacing-induced changes in CaT were
reduced by Y27632 (Figure 6C), indicating that also this effect
is RhoA-mediated.
3.5. HSPB8, but not HSPB1, HSPB6, and HSPB7, reduces
activation of RhoA GTPases after tachypacing
To test whether the protective effect of HSPB members is related
to a direct modulation of the RhoA GTPaseactivity, RhoA GTPase
Figure 2. Overexpression of HSPB6, HSPB7 or HSPB8 do not
result in changes in endogenous HSPB1 levels. (A) Representative
Western blot showing that the endogenous HSPB1 levels in transfected
HSPB6, HSPB7 and HSPB8 overexpressing HL-1 myocytes are not
changed in normal paced myocytes (1 Hz) or tachypaced myocytes
(4 Hz). (B) Corresponding mean data (n=3 experiments/group).
doi:10.1371/journal.pone.0020395.g002
Figure 3. HSPB6, HSPB7, HSPB8 protective effect is indepen-
dent of HSPB1. (A) Western blot showing efficient siRNA-induced
HSPB1 knockdown in HL-1 mycoytes. (B) Recordings of CaT for mock
and siRNA construct. HL-1 myocytes were transfected with mock or
siRNA construct for 5 days before study. One day before tachypacing,
the myocytes were transfected with HSPB6, HSPB7 or HSPB8 and
subjected to normal pacing (1 Hz) or tachypacing (4 Hz). (C) Mean CaT
data. The cardioprotective effect of HSPB6, HSPB7 or HSPB8 was not
blocked by HSPB1 suppression. ***P,0.001 vs control tachypaced
(4 Hz). # P,0.001 vs control normal paced (1 Hz).
doi:10.1371/journal.pone.0020395.g003
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(4 Hz) HL-1 myocytes transfected with the individual HSPB
members. None of the HSPB members affected RhoA GTPase
activity in 1 Hz paced HL-1 myocytes (Figure S2). Only HSPB8
transfected HL-1 myocytes revealed significantly reduced activation
of RhoA GTPase upon 6 hours of tachypacing and all other
(protective) HSPB members were ineffective (Figure 7), suggesting
that their protective effects against tachycardia remodeling are
downstream of RhoA GTPase activation.
3.6. HSPB1, HSPB6, and HSPB7 prevent G-to-F actin
polymerization
To investigate whether HSPB1, HSPB6, and HSPB7, rather
than affecting RhoA GTPase activation, may ameliorate the
downstream consequences of activated RhoA GTPase, we
measured their effect on the polymerization of G-actin to F-actin
and also the depolymerization, using an in vitro polymerization kit.
Base-line fluorescence of G/F-actin ratios were measured for three
minutes, after which cell lysates from HL-1 myocytes transfected
Figure 4. HSPB1, HSPB6 and HSPB7 coocalize with tachypacing-induced F-actin stress fibers in HL-1 myocytes. Immunofluorescent
staining of F-actin stress fibers (red) and HSPB positive myocytes (green), in tachypaced HL-1 myocytes (4 Hz). A normal paced (1 Hz) HSPB1
transfected myocyte was shown as a representative control example.
doi:10.1371/journal.pone.0020395.g004
Figure 5. HSPB1, HSPB6, HSPB7 and HSPB8 overexpression is associated with a reduction in the amount of tachypacing-induced F-
actin stress fibers in HL-1 myocytes. (A) Immunofluorescent staining of F-actin stress fibers (red) and HSPB7 positive myocytes (green), in
tachypaced HL-1 myocytes (4 Hz). HSPB7 positive myocytes reveal less stress fibers. (B) Quantification of the amount of F-actin stress fibers in HSPB
transfected HL-1 myocytes after normal pacing (1 Hz) or tachypacing (4 Hz). (C) Quantification of the amount of colocalization of transfected HSPB
with F-actin stress fibers. *P,0.05, **P,0.01, ***P,0.001 vs control tachypaced myocytes (4 Hz), #P,0.05 vs control normal paced (1 Hz).
doi:10.1371/journal.pone.0020395.g005
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added (Figure 8). The non-protective HSPB5 was used as a
control. When polymerization buffer was added to the baseline G/
F-actin, a rapid increase in the conversion of G-to-F actin ratio
was observed, indicative of fast actin polymerization. Addition of
lysates from HSPB1 transfected cells as well the addition of 0.5 mg
recombinant human HSPB1 induced depolymerization of F-actin.
Although less effective, lysates from HSPB6 also induce depoly-
Figure 6. Tachypacing induces gradual activation of RhoA-GTPase and consequently formation of F-actin stress fibers and
reduction in CaT in HL-1 myocytes. (A) HL-1 myocytes were tachypaced upto 8 hours and activation of RhoA-GTPase was measured. (B) Left:
Examples of immunofluorescent staining of F-actin stress fibers (red) in tachypaced HL-1 myocytes (4 Hz, 4 and 8 hours), normal paced (1 Hz) and
tachypaced HL-1 myocytes pretreated with the ROCK inhibitor Y27632 (4 Hz, 8 hours). Right: quantification of the fluorescence intensity of F-actin in
the conditions as indicated. (C) Top: Original recordings of CaT in 1 myocyte each from groups indicated. Below: Mean CaT data of normal (1 Hz) and
tachypaced (4 Hz) HL-1 myocytes and tachypaced myocytes pretreated with Y27632. ***P,0.001 Y27632 tachypaced vs control tachypaced (4 Hz),
#P,0.001 vs control normal paced (1 Hz).
doi:10.1371/journal.pone.0020395.g006
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prevent actin polymerization but did not show an effect on
depolymerization. In contrast to the findings of HSPB1, HSPB6
and HSPB7 in preventing the formation and/or stimulating the
depolymerization of F-actin stress fibers, addition of lysates from
HSPB8 transfected cells resulted in actin polymerization, although
the levels of polymerization were reduced compared to lysates of
the non-protective HSPB5 transfected myocytes, which showed
near to normal polymerization.
These results together suggest that HSPB1, HSPB6 and HSPB7
may prevent tachycardia remodeling by directly preventing the
formation and/or stimulating the depolymerization of F-actin
stress fibers downstream of active RhoA GTPase, whilst HSPB8
mainly acts at the level of tachypacing-induced RhoA GTPase
activation.
Discussion
Previously, we showed HSPB1 to protect in HL-1 myocytes
against tachycardia remodeling and to preserve normal Ca
2+
transients as well as the actin cytoskeleton upon tachypacing [2;3].
In the current study we found that, in addition to HSPB1, also
some other members of the HSPB family (HSPB6, HSPB7 and
HSPB8) display protective effects against tachypacing-induced
remodeling. Interestingly, all protective HSPB members reduced
the formation of F-actin stress fibers, although their modes of
action differs. Whereas HSPB8 interfered with tachypacing-
induced RhoA GTPase activity, HSPB1, HSPB6, and HSPB7
did not. HSPB1, HSPB6 and HSPB7 were found to directly
inhibit G- to F-actin polymerization and/or stimulate depolymer-
ization, indicating a protective role against tachycardia remodeling
downstream of RhoA GTPase activation.
Role of Rho GTPases in induction of AF
The current study revealed a prime role for tachypacing-
induced RhoA GTPase activity and consequently F-actin stress
fiber formation in reductions in calcium transients. This finding is
in line with studies revealing an important role for Rho GTPases,
including RhoA and Rac1, in formation of F-actin stress fibers[22]
and the initiation of AF [23;24]. Consistently, experimental studies
showed that activation of RhoA GTPases result in conduction
disturbances and cardiac dysfunction similar to those described in
AF [25;26]. Rho GTPases represent a family of small GTP-
binding proteins involved in cell cytoskeleton organization,
migration, transcription, and proliferation. Rho GTPases have
gained considerable recognition as powerful regulators of actin
cytoskeletal organization in the heart [22]. It was observed that
active Rho GTPases stimulate the conversion of G-actin to F-
actin, which results in cytoskeletal injury including changes in
calcium signaling, conduction disturbances and contractile
dysfunction [13–16], which are all substrates for the development
of AF [25;26]. Actin stress fiber assembly and contraction are
predominantly mediated by Rho-associated serine/threonine
kinase (ROCK), a major down-stream effector of the Rho
pathway. Consistent with all of the above, we now show that
tachypacing activates RhoA and that inhibition of ROCK, its
effector of actin polymerization, prevents tachypacing-induced
reductions in CaT.
The HSPB family
Whereas all HSPB members are characterized by the presence
of a conserved crystallin domain, this domain is flanked by N- and
C-termini that shows large sequence divergence between the
members (Table 1) [5;8]. Also, the four members (HSPB1,
HSPB6, HSPB7 and HSPB8) that we found to have protective
effects against tachycardia remodeling show, besides sequence
divergence, a number of structural and functional differences (see
below). Interestingly, however, all four members, together with the
non-protective HSPB5, show high basal expression in heart tissue
(Table 1). In addition, three members (HSPB1, HSPB6, HSPB7)
seemed to act similar in AF protection, i.e. preventing actin
remodeling downstream of RhoA-activation. Only HSPB8
appears to directly affect RhoA-activation. So, the question is
what are the characteristics shared by these members and, in
addition, what are the differences between them that can explain
their protective effects on tachypacing-induced remodeling?
In cell-free assays, small HSPs have been shown to act as ATP-
independent ‘‘holdases’’, maintaining unfolded or misfolded
proteins in a folding competent, non-aggregated state, hereby
supporting refolding by ATP-regulated chaperones, in particular
Figure 7. HSPB8 reduces activation of RhoA-GTPase during
tachypacing in HL-1 myocytes. HL-1 myocytes were transfected
with HSPB1, HSPB5, HSPB6, HSPB7, HSPB8, or empty plasmid (pcDNA)
and subjected to tachypacing (4 Hz, 6 hours). Activation of RhoA-
GTPase in tachypaced (4 Hz) HL-1 myocytes, transfected with plasmids
as indicated, is shown.
* P,0.05 vs control tachypaced myocytes (4 Hz).
doi:10.1371/journal.pone.0020395.g007
Figure 8. HSPB1, HSPB6, and HSPB7 attentuate F-actin stress
fiber formation in vitro. Cell-lysates from HL-1 myocytes transfected
with HSPB1, HSPB5, HSPB6, HSPB7, or HSPB8 and recombinant human
HSPB1 were used to measure influence of HSPB members on
polymerization of G-actin to F-actin and also the depolymerization.
** P,0.01 vs lysates of HSPB5 transfected myocytes at 20 minutes
incubation,
*** P,0.001 vs lysates of HSPB5 transfected myocytes at 20
minutes incubation.
doi:10.1371/journal.pone.0020395.g008
Small HSPs Protect against Tachycardia Remodeling
PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e20395the HSP70 machinery [8]. In cellular assays, however, of the four
cardioprotective HSPB members, only HSPB1 seems to support
such refolding reaction [27;28]. Moreover, HSPB5 also shares this
activity [28], but did not reveal protective effects against
tachycardia remodeling. This finding indicates that such a
chaperone-like activity is not of prime importance to the HSPB-
mediated protective effects as reported in the current study.
Several members of the HSPB family, including HSPB6,
HSPB7 and HSPB8 were recently shown to be able to assist in
the clearance of stress-induced misfolded proteins, in part through
interaction with (HSPB7) or activation of (HSPB8) the macro-
autophagy machinery [28–30]. Yet, this activity is not shared by
e.g. HSPB1 whilst HSPB9 that also can enhance clearance of
misfolded proteins [28], albeit likely via proteasomal degradation
[31] had no effect on AF. So, the clearance of misfolded proteins
seems not to be a common target of all cardioprotective HSP
members.
Another feature shared amongst many HSPB members is their
dynamic (de)oligomerisation [5;8]. This characteristic has been
suggested to be crucial for e.g. the ability of HSPB1 to interact
with several cytoskeletal components, including actin, intermediate
filaments, and microtubules [7;32]. Yet, in cells HSPB7 and
HSPB8 do not appear to be present in large oligomeric structures
[31;33] implying also that this does not edify their protective role
against tachycardia remodeling. However, all protective HSPB
members can be found in cells as non-oligomeric (most likely
dimeric) proteins as well. For HSPB1, dimers have been suggested
to be the active species in regulating actin (re)polymerization after
stress [34]. Also for HSPB6 stress-induced translocation to actin of
the myofibrils has been reported, which has been associated with
improved heart function [32]. Also HSPB7 translocates from
cytosol to the Z-/I-area of myofibrils, and thereby exerts a
protective effect to ischemic stress [21]. This interaction may be
mediated via a-filamin, an actin-binding protein [35]. All of this is
consistent with our current findings that HSPB1, HSPB6 and
HSPB7 are associated with F-actin stress fibers upon tachypacing
and the fact that they can directly prevent actin polymerization, an
effect that occurs in living cells as a down-stream effect of Rho
activation. In addition, the findings also suggest that chaperone-
like (refolding or clearance) function and actin protection are
distinct, uncoupled functions of these HSPB members. For
HSPB8, the remaining AF protecting HSPB member, no direct
association with actin and/or microtubules has been reported so
far. Although HSPB8 is highly expressed in heart and muscle and
anti-HSPB8 antibodies decorate sarcomeres [30], only a weak
association with F-actin stress fibers after tachypacing was
observed in the current study. Moreover, we only found weak
attenuating effects of HSPB8 on actin polymerization. So, the
protective effects of HSPB8 against tachycardia remodeling seem
distinct from that of the other HSPB members. Consistently, we
indeed observed that HSPB8 was the only member that directly
affected tachypacing-induced RhoA activation. How HSPB8 may
modulate this effect remains an enigma, but maybe its unique role
within the HSPB family in activating autophagy [28;29] may be
important. Autophagy may prevent protein aggregate formation
that served as an early trigger for RhoA activation. Indeed,
preventing aggregate formation has been suggested as the mode by
which HSPB8 can prevents desmin-related cardiomyopathy [36].
The present study demonstrates that RhoA activation plays a
central role in tachypacing-induced myocyte remodeling. This
remodeling can be prevented by some, but not all, members of the
HSPB family. This protection is not directly related to canonical
chaperone-like function of these HSPB members, but involves
preventionofRhoAactivation(HSPB8)oritsdownstreamactionon
actin remodeling (HSPB1,HSPB6,HSPB7).The findingswidenthe
possibilities for the identification of novel therapeutic approaches
directed at RhoA activating components or boosting the expression
of one or more of the cardioprotective HSPB members.
Supporting Information
Figure S1 Tachypacing induces a progressive reduction
in CaT. A) Original recordings of CaT in 1 myocyte each for a
time period as indicated. B) Mean CaT data in myocytes
tachypaced at 4 Hz or normal paced at 1 Hz. #P,0.001
(TIF)
Figure S2 No effect of HSPBs on activation of RhoA-
GTPase in normal paced HL-1 myocytes. HL-1 myocytes
Table 1. Characteristics of small HSPB members.
Gene
Name
Protein
Name
Alternative
Name
Sequence
Identity
Molecular
Size (kDa)
Heat
Inducibility
Expression
in Heart Other tissue expression
HSPB1 HSPB1 Hsp25, HSP27,
HSP28
100% 22.783 Yes +++ Uterus, skin, platelets, brain,
kidney, some tumor cells
HSPB2 HSPB2 MKBP 36% 20.233 No + Skeletal muscle
HSPB3 HSPB3 HSPL27 23% 16.966 + Skeletal muscle
HSPB4 HSPB4 aA-crystallin,
CRYAA, CRYA1
36% 19.909 No - Lens of eye, spleen
HSPB5 HSPB5 aB-crystallin,
CRYAB, CRYA2
38% 20.159 Yes ++++ Lens of eye, vascular wall
cells, lung, kidney, brain,
some tumor cells
HSPB6 HSPB6 Hsp20, p20 34% 17.136 No ++ Skeletal muscle, stomach,
liver, lung, kidney, platelet
HSPB7 HSPB7 cvHsp 20% 18.611 ? ++++++ Skeletal muscle
HSPB8 HSPB8 Hsp22, H11 34% 21.604 Yes ++ Skeletal muscle, stomach,
liver, lung, kidney, brain
HSPB9 HSPB9 FLJ27437 19% 17.486 ? - Testis
HSPB10 HSPB10 ODF1 17% 28.366 ? - Testis
doi:10.1371/journal.pone.0020395.t001
Small HSPs Protect against Tachycardia Remodeling
PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e20395were transfected with HSPB1, HSPB5, HSPB6, HSPB7, HSPB8,
or empty plasmid (pcDNA) and subjected to normal pacing (1 Hz).
Activation of RhoA-GTPase was determined by G-LISA.
(TIF)
Movie S1 Time-lapse movie shows CaT after 8 hours
normal pacing (1 Hz) of HL-1 myocytes. Images were
acquired at 2 ms intervals.
(AVI)
Movie S2 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) of HL-1 myocytes. Images were acquired
at 2 ms intervals.
(AVI)
Movie S3 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB1 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S4 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB2 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S5 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB3 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S6 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB4 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S7 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB5 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S8 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB6 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S9 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB7 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S10 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB8 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S11 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB9 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S12 Time-lapse movie shows CaT after 8 hours
tachypacing (4 Hz) in HSPB10 overexpressing HL-1
myocytes. Images were acquired at 2 ms intervals.
(AVI)
Movie S13 Time-lapse movie shows CaT after 8 hrs
tachypacing (4 Hz) in mock treated HL-1 myocytes
transfected with HSPB6. Images were acquired at 2 ms
intervals.
(AVI)
Movie S14 Time-lapse movie shows CaT after 8 hrs
tachypacing (4 Hz) in siRNA treated HL-1 myocytes
transfected with HSPB6. Images were acquired at 2 ms
intervals.
(AVI)
Movie S15 Time-lapse movie shows CaT after 8 hrs
tachypacing (4 Hz) in mock treated HL-1 myocytes
transfected with HSPB7. Images were acquired at 2 ms
intervals.
(AVI)
Movie S16 Time-lapse movie shows CaT after 8 hrs
tachypacing (4 Hz) in siRNA treated HL-1 myocytes
transfected with HSPB7. Images were acquired at 2 ms
intervals.
(AVI)
Movie S17 Time-lapse movie shows CaT after 8 hrs
tachypacing (4 Hz) in mock treated HL-1 myocytes
transfected with HSPB8. Images were acquired at 2 ms
intervals.
(AVI)
Movie S18 Time-lapse movie shows CaT after 8 hrs
tachypacing (4 Hz) in siRNA treated HL-1 myocytes
transfected with HSPB8. Images were acquired at 2 ms
intervals.
(AVI)
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